跳至主要内容
临床试验/CTRI/2020/03/023895
CTRI/2020/03/023895进行中(未招募)4 期

Optimum dose of oral folic acid supplementation in transfusion-dependent thalassemia major

niversity college of Medical Sciences and Guru Teg Bahadur Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Transfusion dependent thalassemia major patients aged 5 to 18 years will be included

排除标准

  • Patients deficient in folate and Vit. B12, splenectomized patients, patients with chronic liver disease, Hepatitis B or C infection, patients taking medicines affecting folate metabolism (cotrimoxazole or methotrexate) will be excluded

研究者

发起方
niversity college of Medical Sciences and Guru Teg Bahadur Hospital

相似试验